Telemedicine

DEA Extends Telemedicine Prescription of Controlled Medicines

October 11, 2023 - In an announcement on October 6, 2023, the United States Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced that they would extend the COVID-19 telemedicine prescription flexibilities for controlled medicines. The statement was submitted to the Federal Register on September 29, 2023, under the...

Read More


More Articles

Expanding Product Portfolios Through Technology Integration

by Alivia Kaylor

The biotechnology and pharmaceutical industries have long been at the forefront of technological innovation, leveraging cutting-edge advancements to improve healthcare outcomes and enhance product portfolios.   In an era where...

The Policy Problem Behind Adderall’s Pharmaceutical Supply Chain Crisis

by Hayden Schmidt

Attention deficit/hyperactivity disorder (ADHD) is a prevalent mental health condition described as a generalizable inability to pay attention or control impulsive behavior and a tendency to be overactive. The Centers for Disease Control...

DEA Proposes Updated Rules to COVID-19 Telemedicine Flexibilities

by Veronica Salib

On February 24, 2023, the United States Drug Enforcement Agency (DEA) issued a press release announcing its proposal for updated telemedicine flexibility rules. At the start of the COVID-19 pandemic...

Understanding the Rise of Digital Pharmacies

by Veronica Salib

As the world advances in the digital era, it is no surprise that more and more consumers are turning to the internet for healthcare information, advice, and even medications. While online pharmacies have been around for decades, they...

Recent Articles